prednisone
- Product NDC
- 68788-8184
- 11-digit product format
- 687888184
- Labeler code
- 68788
- Product ID
- 68788-8184_f1c95e0d-f82e-46e8-bd54-f1a456e2101f
- Type
- HUMAN PRESCRIPTION DRUG
- Nonproprietary name
- PREDNISONE
- Dosage form
- TABLET
- Route
- ORAL
- Labeler
- Preferred Pharmaceuticals Inc.
- Application
- ANDA209727
- Marketing category
- ANDA
- Marketing start
- 2022-05-06
- Substance
- PREDNISONE
- Active strength
- 2.5 mg/1
- Pharmacologic classes
- Corticosteroid Hormone Receptor Agonists [MoA], Corticosteroid [EPC]
- NDC exclude flag
- No
- Listing certified through
- 2026-12-31
- Current FDA listing
- Yes
Additional Listing Data#
- Finished product
- Yes
- Brand name base
- prednisone
- Listing expiration
- 2026-12-31
Active Ingredients#
Ingredient, Strength table| Ingredient | Strength |
|---|
| PREDNISONE | 2.5 mg/1 |
Harmonized Identifiers#
Field, Values table| Field | Values |
|---|
| Unii | VB0R961HZT |
| Rxcui | 198146 |
DailyMed Product Concepts#
DailyMed Package Descriptions#
Package NDC, Product, Description table| Package NDC | Product | Description | Form | Quantity | Strength | SPL version |
|---|
| 68788-8184-1 | prednisone | 15 in 1 BOTTLE | TABLET | 15 | | 4 |
| 68788-8184-3 | prednisone | 30 in 1 BOTTLE | TABLET | 30 | | 4 |
DailyMed Dashboard NDC Coverage#
NDC, Dashboard title, SPL version table| NDC | Dashboard title | SPL version | Validation | Dashboard ZIP |
|---|
| 68788-8184 | PREDNISONE TABLET [PREFERRED PHARMACEUTICALS INC.] | 3 | Current NDC, Legacy NDC, 2 package rows | 20240802_930b5eea-3ec8-47df-a76d-1e0bc0b5c5b2.zip |
DailyMed RxNorm Mappings#
Packages#
Package NDC, 11-digit format, Description table| Package NDC | 11-digit format | Description | Units | Marketing start | Marketing end | Sample | Exclude flag | Status |
|---|
| 68788-8184-1 | 68788818401 | 15 TABLET in 1 BOTTLE (68788-8184-1) | 15 tablet | 2024-07-31 | | No | No | Historical |
| 68788-8184-3 | 68788818403 | 30 TABLET in 1 BOTTLE (68788-8184-3) | 30 tablet | 2022-05-06 | 0000-00-00 | No | No | Current |